INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 84 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 6.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $556,000 | +164.8% | 70,903 | +133.8% | 0.02% | +200.0% |
| Q4 2016 | $210,000 | +8.2% | 30,326 | +45.8% | 0.01% | 0.0% |
| Q3 2016 | $194,000 | -82.4% | 20,795 | -82.5% | 0.01% | -78.3% |
| Q2 2016 | $1,101,000 | +825.2% | 119,158 | +771.0% | 0.02% | +666.7% |
| Q1 2016 | $119,000 | -76.1% | 13,681 | -81.5% | 0.00% | -62.5% |
| Q4 2015 | $497,000 | +109.7% | 74,002 | +80.7% | 0.01% | +100.0% |
| Q3 2015 | $237,000 | +22.2% | 40,964 | +71.9% | 0.00% | +33.3% |
| Q2 2015 | $194,000 | -34.2% | 23,832 | -34.0% | 0.00% | -50.0% |
| Q1 2015 | $295,000 | +98.0% | 36,133 | +122.6% | 0.01% | +200.0% |
| Q4 2014 | $149,000 | -34.6% | 16,233 | -30.0% | 0.00% | -50.0% |
| Q3 2014 | $228,000 | +9.6% | 23,195 | +20.4% | 0.00% | +33.3% |
| Q2 2014 | $208,000 | – | 19,266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |